Feline Therapeutic Antibody Discovery Services
Creative Biolabs offers an end-to-end, integrated solution for creating therapeutic antibodies for cats, spanning from initial discovery to the generation of fully felinized and chimeric candidates prepared for preclinical studies. Our platform is designed to expedite the creation of next-generation veterinary biologics aimed at treating feline diseases.
Enhancing Feline Health with Therapeutic Antibodies
Cats are susceptible to a range of severe conditions, such as cancer, infectious diseases, autoimmune disorders, and chronic inflammatory illnesses. Monoclonal antibodies (mAbs) have revolutionized human medicine, and this powerful therapeutic approach is now being adapted to improve the health and lifespan of feline companions. However, creating safe and effective antibody therapies for cats requires deep expertise in their distinct immunological characteristics.
We are at the forefront of veterinary medicine with a specialized platform for feline therapeutic antibody discovery and engineering. Our focus is on generating high-affinity antibodies with minimal immunogenicity, specifically tailored for feline biology. From the initial concept to a developed candidate, our all-in-one solution offers a streamlined process that accelerates timelines and optimizes resources.
Our Integrated Antibody Discovery Services
We deliver a complete range of services that can be customized to your project's unique requirements, whether you are starting from a new target or optimizing an existing antibody for veterinary applications.
Feline Antibody Discovery
Our platform is capable of generating novel, fully feline monoclonal antibodies from the very beginning. By employing advanced techniques like feline-specific phage display libraries, we can isolate highly potent and specific antibodies against your chosen target. This method is the gold standard for minimizing the risk of adverse immune reactions, as the final antibodies are 100% feline in sequence.
Felinized Antibody Discovery
For non-feline antibodies with promising therapeutic potential, we provide expert felinization engineering services. This sophisticated process involves grafting the antigen-binding loops (CDRs) from the original antibody onto a carefully selected feline antibody framework. The resulting felinized antibody retains its high target affinity while significantly reducing its potential to cause an immune response in cats.
Chimeric Canine Antibody Discovery
Creating a chimeric antibody provides a rapid and robust method for adapting a non-feline mAb for therapeutic use in cats. Our service fuses the entire variable region (both heavy and light chains, VH and VL) of your starting antibody with the constant region (CH and CL) of a feline antibody. This chimeric molecule is substantially less immunogenic than the original non-feline antibody, making it a viable therapeutic candidate.
Service Workflow
Our mission is to provide an efficient, fully integrated workflow that guides your project from initial target assessment to a comprehensively characterized lead antibody candidate. Our all-in-one solution removes the complexity of coordinating with multiple service providers, simplifying your research and development pipeline.
| Workflow | Description |
|---|---|
| Target Validation & Antigen Design | We help you validate your therapeutic target and design the ideal antigen for generating a targeted immune response. |
| Antibody Discovery & Screening | We use state-of-the-art platforms like phage display and B-cell cloning to discover antibodies with optimal binding characteristics. |
| Engineering & Optimization | We perform felinization or chimerization and optimize for critical attributes like affinity, stability, and production yield. |
| Expression & Production | We offer scalable production of your lead antibody candidates to generate material for essential preclinical studies. |
| Comprehensive Characterization | We provide a complete suite of analytical services to confirm your antibody meets all functional and quality specifications. |
Our Advantages
Partner with Creative Biolabs
Creative Biolabs is committed to advancing companion animal medicine through cutting-edge biologics. Our feline therapeutic antibody discovery service empowers veterinary researchers, biotechnology firms, and pharmaceutical partners to fast-track the development of innovative antibody treatments designed specifically for cats.
By uniting advanced discovery technologies, species-specific scientific expertise, and integrated preclinical services, we offer a direct and reliable path from initial concept to a validated therapeutic candidate.